agilon health, inc. (NYSE:AGL) Short Interest Up 5.1% in November

agilon health, inc. (NYSE:AGL) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 31,940,000 shares, an increase of 5.1% from the November 15th total of 30,390,000 shares. Based on an average daily trading volume, of 4,590,000 shares, the short-interest ratio is presently 7.0 days. Approximately 10.5% of the company’s shares are sold short.

agilon health Stock Performance

agilon health stock opened at $2.01 on Wednesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health has a 12 month low of $1.50 and a 12 month high of $13.45. The company has a fifty day moving average price of $2.40 and a two-hundred day moving average price of $4.32. The company has a market cap of $826.10 million, a PE ratio of -2.13 and a beta of 0.51.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the firm posted ($0.06) earnings per share. Research analysts expect that agilon health will post -0.52 earnings per share for the current year.

Insider Buying and Selling at agilon health

In related news, Director Karen Mcloughlin bought 25,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The stock was bought at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Diana Mckenzie bought 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were bought at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the acquisition, the director now owns 51,319 shares in the company, valued at approximately $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 90,000 shares of company stock valued at $198,100 over the last ninety days. Corporate insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

Several institutional investors have recently made changes to their positions in AGL. Arizona State Retirement System grew its position in shares of agilon health by 2.5% during the second quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock worth $562,000 after acquiring an additional 2,070 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in agilon health during the 3rd quarter valued at about $28,000. CWM LLC grew its position in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after purchasing an additional 7,288 shares during the last quarter. Signaturefd LLC increased its stake in shares of agilon health by 166.2% in the second quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock valued at $77,000 after purchasing an additional 7,398 shares during the period. Finally, Wedbush Securities Inc. raised its holdings in shares of agilon health by 72.6% during the second quarter. Wedbush Securities Inc. now owns 20,710 shares of the company’s stock valued at $135,000 after buying an additional 8,710 shares during the last quarter.

Analyst Upgrades and Downgrades

AGL has been the topic of a number of recent research reports. Evercore ISI reduced their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. TD Cowen decreased their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. Finally, JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Three analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $4.28.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.